🇺🇸 FDA

Company profile · Sponsor

Advicenne

Advicenne S.A.

E4F5223 · EMA pharma EU
Pipeline
1
Drugs
0
Patents
0

Quick answer

Advicenne (E4F5223) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E4F5223
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (1)

Search pipeline →

  1. A Phase I, randomized, controlled, Latin-square, open-label study, to evaluate the effect of ADV7103 on gastric pH under fed and fasting conditions in adult healthy participants.

    Advicenne

    distal renal tubular acidosis (dRTA)

    phase 1 other active

    1 trial

Frequently asked questions

What is Advicenne?

Advicenne (E4F5223) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Advicenne sponsor?

We track 1 ClinicalTrials.gov-linked program for Advicenne, including A Phase I, randomized, controlled, Latin-square, open-label study, to evaluate the effect of ADV7103 on gastric pH under fed and fasting conditions in adult healthy participants.. Open each program for phase, modality, NCT IDs, and indication details.

Where does Advicenne company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.